[go: up one dir, main page]

AU2676600A - Pharmaceutical composition for balanic transmucosal administration of alfuzosin - Google Patents

Pharmaceutical composition for balanic transmucosal administration of alfuzosin

Info

Publication number
AU2676600A
AU2676600A AU26766/00A AU2676600A AU2676600A AU 2676600 A AU2676600 A AU 2676600A AU 26766/00 A AU26766/00 A AU 26766/00A AU 2676600 A AU2676600 A AU 2676600A AU 2676600 A AU2676600 A AU 2676600A
Authority
AU
Australia
Prior art keywords
balanic
alfuzosin
pharmaceutical composition
transmucosal administration
transmucosal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26766/00A
Inventor
Anne Charlier
Alain Cuine
Alain Dufour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU2676600A publication Critical patent/AU2676600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26766/00A 1999-02-16 2000-02-14 Pharmaceutical composition for balanic transmucosal administration of alfuzosin Abandoned AU2676600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9901803 1999-02-16
FR9901803A FR2789586A1 (en) 1999-02-16 1999-02-16 Compositions containing alfuzosin for treatment of erectile dysfunction, applied by balanic transmucosal administration
PCT/FR2000/000358 WO2000048570A1 (en) 1999-02-16 2000-02-14 Pharmaceutical composition for balanic transmucosal administration of alfuzosin

Publications (1)

Publication Number Publication Date
AU2676600A true AU2676600A (en) 2000-09-04

Family

ID=9542029

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26766/00A Abandoned AU2676600A (en) 1999-02-16 2000-02-14 Pharmaceutical composition for balanic transmucosal administration of alfuzosin

Country Status (3)

Country Link
AU (1) AU2676600A (en)
FR (1) FR2789586A1 (en)
WO (1) WO2000048570A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2869232B1 (en) * 2004-04-21 2007-09-21 Gattefosse Sas Soc Par Actions NOVEL PHARMACEUTICAL OR COSMETIC EXCIPIENTS BASED ON CYCLIC ACETALS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
FR2694495B1 (en) * 1992-08-05 1994-09-23 Synthelabo Transdermal pharmaceutical preparation containing alfuzosin.
DE4309830C1 (en) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Transdermal patches for oestradiol admin. - contg. isopropylidene mono- or di-glycerol as penetration enhancer
CA2215307A1 (en) * 1995-03-14 1996-09-19 Vivus, Incorporated Pharmaceutical compositions and kits for preventing erectile dysfunction
JPH1045597A (en) * 1996-07-31 1998-02-17 Toko Yakuhin Kogyo Kk External preparation for treating hypertension and urinary disturbance
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction

Also Published As

Publication number Publication date
FR2789586A1 (en) 2000-08-18
WO2000048570A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
AU2331801A (en) Improved pharmaceutical compositions for poorly soluble drugs
IL149186A0 (en) Pharmaceutical compositions providing enhanced drug concentrations
AU4334700A (en) Pharmaceutical dosage form for pulsatile delivery of methylphenidate
AU3556400A (en) Pharmaceutical compositions
AU2177001A (en) Use of indirubine derivatives for making medicines
GB2355656B (en) Pharmaceutical compositions for oral and topical administration
AU4328800A (en) Pharmaceutical formulation
AU2001238346A1 (en) Modification of biopolymers for improved drug delivery
AU4304400A (en) Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
HUP0200468A3 (en) Resorcinol derivatives and pharmaceutical compositions containing them
AU5460800A (en) Pharmaceutical transdermal compositions
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AU6460400A (en) Pharmaceutical compositions
AU2670600A (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
AU7937500A (en) Pharmaceutical composition containing midazolam
AU6460200A (en) Pharmaceutical compositions
AU5072000A (en) Pharmaceutical composition for nasally administering water-soluble active substances
AU3926000A (en) Methods and compositions for drug delivery
AU2002212863A1 (en) Stable pharmaceutical form of an anticancer drug
HUP0200993A3 (en) Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
AU3839900A (en) Pharmaceutical formulation
AU6460100A (en) Pharmaceutical compositions
AU6460300A (en) Pharmaceutical compositions
AU2676600A (en) Pharmaceutical composition for balanic transmucosal administration of alfuzosin
GB9902227D0 (en) Pharmaceutical composition for topical administration

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase